Overview
Glutathione (γ-L-glutamyl-L-cysteinyl-glycine, GSH) is a tripeptide composed of glutamate, cysteine, and glycine that serves as the body's most abundant and important intracellular antioxidant. Present in virtually every cell at millimolar concentrations, glutathione is central to cellular defense against oxidative stress, detoxification of xenobiotics, immune function, and the regulation of critical cellular processes including DNA synthesis and repair.
Glutathione levels decline naturally with age, chronic illness, environmental toxin exposure, poor nutrition, and chronic stress. This depletion is associated with increased vulnerability to oxidative damage, impaired detoxification capacity, weakened immune function, and accelerated aging. Research has linked low glutathione levels to numerous conditions including neurodegenerative diseases, liver disease, cardiovascular disease, cancer, and chronic fatigue.
The challenge with glutathione supplementation has traditionally been bioavailability—oral glutathione is extensively degraded by gastrointestinal enzymes and has poor absorption in its reduced (active) form. This has driven interest in alternative delivery methods including IV infusion, liposomal formulations, and precursor supplementation (N-acetylcysteine, glycine, glutamine), as well as injectable glutathione in clinical settings.
This guide examines glutathione's essential biological roles, the evidence for supplementation across various health conditions, comparative bioavailability of different delivery methods, and the safety profile of glutathione restoration strategies.
Quick facts
- Mechanism
- Master endogenous tripeptide antioxidant and detoxification cofactor
- Primary use
- Antioxidant Defense & Detoxification
- Evidence
- strong
- FDA
- Not approved
- Route
- IV infusion, subcutaneous injection, oral (liposomal), inhaled, or topical
- Typical results
- Measurable increases in blood glutathione within 1–2 weeks of supplementation
Chemical information
Glutathione (C₁₀H₁₇N₃O₆S) is a anti-inflammatory compound with a molecular weight of 307.32 g/mol. Its structural characteristics underpin its biological activity in anti-inflammatory and immune modulation.
How Glutathione works
Glutathione operates through multiple interconnected mechanisms: as a direct antioxidant neutralizing reactive oxygen and nitrogen species, as a substrate for glutathione peroxidase enzymes that reduce hydrogen peroxide and lipid peroxides, and as a cofactor for glutathione S-transferases that conjugate and detoxify electrophilic xenobiotics, drugs, and carcinogens for excretion.
The glutathione redox cycle is central to cellular antioxidant defense. Reduced glutathione (GSH) donates electrons to neutralize ROS and is oxidized to glutathione disulfide (GSSG). GSSG is then recycled back to GSH by glutathione reductase using NADPH from the pentose phosphate pathway. The GSH:GSSG ratio (normally >100:1) serves as a key indicator of cellular oxidative stress, and its maintenance is critical for cell survival.
In phase II detoxification, glutathione S-transferases catalyze the conjugation of glutathione with electrophilic compounds including drug metabolites, environmental toxins (heavy metals, pesticides), and endogenous toxins (malondialdehyde, 4-hydroxynonenal). These conjugates are more water-soluble and are exported from cells via MRP (multidrug resistance protein) transporters for excretion via bile and urine.
Glutathione also plays essential roles in immune function: it regulates lymphocyte proliferation and NK cell cytotoxicity, modulates cytokine production (shifting toward Th1 responses), and is required for optimal T-cell function. HIV, sepsis, and other conditions characterized by immune dysfunction are consistently associated with depleted glutathione levels, and repletion has been shown to improve immune parameters.
- Direct antioxidant: Neutralizes superoxide, hydroxyl radicals, and peroxynitrite
- Glutathione peroxidase cofactor: Essential for enzymatic reduction of hydrogen peroxide and lipid hydroperoxides
- Phase II detoxification: Conjugates electrophilic toxins via glutathione S-transferases for excretion
- GSH:GSSG redox balance: Maintains cellular redox potential critical for protein function
- Immune regulation: Required for lymphocyte proliferation, NK cell activity, and Th1 cytokine production
- Vitamin C/E recycling: Regenerates oxidized forms of vitamins C and E
Pharmacokinetics
| Parameter | Value | Significance |
|---|---|---|
| IV bioavailability | 100% | Direct systemic delivery; most rapid GSH elevation |
| Oral (standard) bioavailability | <5% | Extensive GI degradation; poor absorption |
| Oral (liposomal) bioavailability | ~30–65% | Lipid encapsulation protects from degradation |
| Intracellular half-life | ~2–3 hours | Rapidly consumed; continuous synthesis required |
| Endogenous production | ~8–10 g/day | Body produces large quantities; supplementation augments |
| NAC conversion | Precursor; rate-limiting step | N-acetylcysteine provides cysteine for GSH synthesis |
Dosing & administration
Glutathione dosing varies by indication and individual factors. No FDA-approved dosing exists for this compound; protocols in the literature derive from limited clinical or preclinical data and practitioner experience.
Any use should be conducted under qualified medical supervision with appropriate monitoring of safety markers.
Important: These dosing ranges are not FDA-approved. Any use should be under qualified medical supervision.
Side effects & safety
Safety data for Glutathione is primarily derived from preclinical studies and limited human data. Long-term effects in humans remain incompletely characterized.
Common
- • Mild nausea (IV infusion)
- • Bloating or GI discomfort (oral forms)
- • Sulfurous taste or smell
- • Headache (usually during initial loading)
- • Injection site reactions (subcutaneous)
Serious / potential risks
- • Rare allergic or anaphylactoid reactions to IV glutathione
- • Potential zinc depletion with prolonged high-dose use
- • Theoretical concern about reductive stress in certain contexts
- • May interfere with some chemotherapy mechanisms
Drug interactions
| Medication | Interaction | Recommendation |
|---|---|---|
| Acetaminophen (Tylenol) | Glutathione detoxifies acetaminophen metabolite NAPQI; protective | GSH/NAC is the standard treatment for acetaminophen overdose |
| Chemotherapy agents (cisplatin) | GSH may reduce efficacy of platinum-based chemo | Discuss timing with oncologist; may be used post-cycle for recovery |
| Alcohol | Chronic alcohol depletes hepatic glutathione | Glutathione repletion may support liver recovery; not a license to drink |
| Nitroglycerin | Glutathione may prevent nitrate tolerance | Potentially beneficial co-administration; consult cardiologist |
Storage & handling
Lyophilized (powder)
- • Store at -20°C to 4°C (freezer or refrigerator)
- • Protect from light and moisture
- • Stable for 12–24 months when stored properly
- • Keep in original sealed container until reconstitution
Reconstituted solution
- • Refrigerate at 2–8°C after reconstitution
- • Use bacteriostatic water for multi-dose reconstitution
- • Typical stability: 14–28 days refrigerated
- • Do not freeze reconstituted solution
Cost & availability
| Source | Cost | Notes |
|---|---|---|
| IV infusion clinics | $150–$350 per session | Typical dose: 600–2000mg per infusion |
| Liposomal oral | $30–$80 per month | Most effective oral form; 250–500mg/day typical |
| NAC (precursor) | $10–$25 per month | Cost-effective alternative; 600–1200mg/day |
| Injectable (SC) | $100–$200 per month | Available through compounding pharmacies |
The bottom line
Glutathione is the body's master antioxidant and most important detoxification molecule. While endogenous production is substantial, depletion is common with aging, illness, and environmental stress. Supplementation strategies range from precursor support (NAC, glycine) to direct delivery (IV, liposomal). The evidence for glutathione's importance is overwhelming, though optimal supplementation strategy depends on individual needs and clinical context.
Best for
- • Individuals with documented oxidative stress or glutathione deficiency
- • Liver support and detoxification protocols under medical supervision
- • Immune support during chronic illness or post-illness recovery
- • Anti-aging protocols addressing oxidative damage
Not for
- • During active chemotherapy without oncologist approval
- • As a replacement for addressing root causes of oxidative stress
- • Skin lightening without dermatologist supervision
- • Those expecting glutathione to compensate for poor lifestyle choices
Related compounds
GHK-Cu
Copper peptide that upregulates antioxidant gene expression including glutathione pathways
NAD+
Essential coenzyme providing NADPH for glutathione recycling
KPV
Anti-inflammatory peptide complementing glutathione's oxidative stress defense
LL-37
Antimicrobial peptide supporting immune function alongside glutathione
Frequently asked questions
References
- [1] Forman HJ, Zhang H, Rinna A.. Glutathione: Overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med (2009). doi: 10.1016/j.mam.2008.08.006 PMID: 18926850
- [2] Richie JP, Nichenametla S, Neidig W, et al.. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr (2015). doi: 10.1007/s00394-014-0706-z PMID: 24791752
- [3] Sinha R, Sinha I, Calcagnotto A, et al.. Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function. Eur J Clin Nutr (2018). doi: 10.1038/ejcn.2017.132 PMID: 29368560
- [4] Pizzorno J.. Glutathione!. Integr Med (Encinitas) (2014). PMID: 26770075
- [5] Dröge W, Breitkreutz R.. Glutathione and immune function. Proc Nutr Soc (2000). doi: 10.1017/S0029665100000847 PMID: 11209335